RMRoger A. Moore

Roger A. Moore

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Roger A. Moore has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Phillip A. Wilmarth

    Department of Biochemistry and Molecular Biology, School of Medicine, Oregon Health & Science University

    3 shared publications
  • Suzette A. Priola

    Laboratory of Persistent Viral Diseases and ‡Research Technologies Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton, Montana 59840, United States

    3 shared publications
  • Andrew Timmes

    2 shared publications
  • Suzette A. Priola

    Rocky Mountain Laboratories, Laboratory of Neurological Infections and Immunity, National Institute of Allergy & Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA

    2 shared publications
  • Andrew G. Timmes

    Rocky Mountain Laboratories, National Institute of Allergy & Infectious Disease, Laboratory of Persistent Viral Disease National Institutes of Health

    1 shared publication
  • Bruce Chesebro

    Laboratory of Persistent Viral Diseases and ‡Research Technologies Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton, Montana 59840, United States

    1 shared publication

Latest Publications

  • Open Access

    Proteomics Analysis of Amyloid and Nonamyloid Prion Disease Phenotypes Reveals Both Common and Divergent Mechanisms of Neuropathogenesis

    by Roger A. Moore, Dan E. Sturdevant, Bruce Chesebro, Suzette A. Priola

    Prion diseases are a heterogeneous group of neurodegenerative disorders affecting various mammals including humans. Prion diseases are characterized by a misfolding of the host-encoded prion protein (PrPC) into a pathological isoform termed PrPSc. In wild-type mice, PrPC is attached to the plasma membrane by a glycosylphosphatidylinositol (GPI) anchor and PrPSc typically accumulates in diffuse nonamyloid deposits with gray matter spongiosis. By contrast, when mice lacking the GPI anchor are infected with the same prion inoculum, PrPSc accumulates in dense perivascular amyloid plaques with little or no gray matter spongiosis. In order to evaluate whether different host biochemical pathways were implicated in these two phenotypically distinct prion disease models, we utilized a proteomics approach. In both models, infected mice displayed evidence of a neuroinflammatory response and complement activation. Proteins involved in cell death and calcium homeostasis were also identified in both phenotypes. However, mitochondrial pathways of apoptosis were implicated only in the nonamyloid form, whereas metal binding and synaptic vesicle transport were more disrupted in the amyloid phenotype. Thus, following infection with a single prion strain, PrPC anchoring to the plasma membrane correlated not only with the type of PrPSc deposition but also with unique biochemical pathways associated with pathogenesis.


  • Identification and removal of proteins that co‐purify with infectious prion protein improves the analysis of its secondary structure

    by Roger A. Moore, Andrew G. Timmes, Phillip A. Wilmarth, David Safronetz, Suzette A. Priola

    Prion diseases are neurodegenerative disorders associated with the accumulation of an abnormal isoform of the mammalian prion protein (PrP). Fourier transform infrared spectroscopy (FTIR) has previously been used to show that the conformation of aggregated, infectious PrP (PrPSc) varies between prion strains and these unique conformations may determine strain‐specific disease phenotypes. However, the relative amounts of α‐helix, β‐sheet and other secondary structures have not always been consistent between studies, suggesting that other proteins might be confounding the analysis of PrPSc secondary structure. We have used FTIR and LC‐MS/MS to analyze enriched PrPSc from mouse and hamster prion strains both before and after the removal of protein contaminants that commonly co‐purify with PrPSc. Our data show that non‐PrP proteins do contribute to absorbances that have been associated with α‐helical, loop, turn and β‐sheet structures attributed to PrPSc. The major contaminant, the α‐helical protein ferritin, absorbs strongly at 1652 cm−1 in the FTIR spectrum associated with PrPSc. However, even the removal of more than 99% of the ferritin from PrPSc did not completely abolish absorbance at 1652 cm−1. Our results show that contaminating proteins alter the FTIR spectrum attributed to PrPSc and suggest that the α‐helical, loop/turn and β‐sheet secondary structure that remains following their removal are derived from PrPSc itself.


  • Comparative profiling of highly enriched 22L and Chandler mouse scrapie prion protein preparations

    by Roger A. Moore, Andrew Timmes, Phillip A. Wilmarth, Suzette A. Priola

  • Comparative profiling of highly enriched 22L and Chandler mouse scrapie prion protein preparations

    by Roger A. Moore, Andrew Timmes, Phillip A. Wilmarth, Suzette A. Priola

    Transmissible spongiform encephalopathies (TSEs) or prion diseases are characterized by the accumulation of an aggregated isoform of the prion protein (PrP). This pathological isoform, termed PrPSc, appears to be the primary component of the TSE infectious agent or prion. However, it is not clear to what extent other protein cofactors may be involved in TSE pathogenesis or whether there are PrPSc‐associated proteins which help to determine TSE strain‐specific disease phenotypes. We enriched PrPSc from the brains of mice infected with either 22L or Chandler TSE strains and examined the protein content of these samples using nanospray LC‐MS/MS. These samples were compared with “mock” PrPSc preparations from uninfected brains. PrP was the major component of the infected samples and ferritin was the most abundant impurity. Mock enrichments contained no detectable PrP but did contain a significant amount of ferritin. Of the total proteins identified, 32% were found in both mock and infected samples. The similarities between PrPSc samples from 22L and Chandler TSE strains suggest that the non‐PrPSc protein components found in standard enrichment protocols are not strain specific.


  • Prion protein misfolding and disease

    by Roger A Moore, Lara M Taubner, Suzette A Priola